A Phase 2, Double-blind, Randomized, Placebo-controlled, Multicenter Trial to Assess the Efficacy, Safety, and Tolerability of AGMB-447 in Participants with Idiopathic Pulmonary Fibrosis (INSPIRIA)

Principal Investigator

Dr Peter Saunders

Contact us

Email: emcrf@ouh.nhs.uk

IRAS number

1014396